ENTBF (ENTBF) Stock Price & Analysis
ENTBF (ENTBF) rose 0.00% to USD 0 as of July 25, 2026 at 06:54 UTC, according to Nexqual real-time market data.
ENTBF last closed at USD 0; the session ranged USD 0–0 on volume of 100 shares. Market capitalization is $55,435, with a 52-week range of USD 0–0.1 (OID). Source: Nexqual, July 25, 2026 at 06:54 UTC.
Key Statistics (as of July 25, 2026 at 06:54 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.1 |
| Volume | 100 shares |
| Market Cap | $55,435 |
| Exchange | OID |
Technical Analysis (ENTBF)
Nexqual's technical model rates ENTBF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 06:54 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.6 (neutral) |
| vs SMA50 | Below (USD 0.03) |
| MACD | -0 (negative) |
Analyst Ratings (ENTBF)
Wall Street analysts rate ENTBF "None", per Nexqual as of July 25, 2026 at 06:54 UTC.
| Consensus Rating | None |
|---|
Earnings (ENTBF)
Source: Nexqual, July 25, 2026 at 06:54 UTC.
Financials & Fundamentals (ENTBF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 62.04 |
| Total Cash | $324,308 |
| Total Debt | $0 |
Source: Nexqual, July 25, 2026 at 06:54 UTC.
Financial Health Score (ENTBF)
Nexqual rates ENTBF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 06:54 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $324K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$91K |
| Efficiency | Mixed — No data |
Ownership (ENTBF)
| Insider Ownership | +2.91% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 13.86M |
| Float | 11.71M |
Source: Nexqual, July 25, 2026 at 06:54 UTC.
Leadership (ENTBF)
ENTBF is led by Timothy Ko (age 39), President, CEO, Corporate Secretary & Director, per Nexqual as of July 25, 2026 at 06:54 UTC.
| President, CEO, Corporate Secretary & Director | Timothy Ko (age 39) |
|---|---|
| Interim Chief Financial Officer | Soo-Whan Kim |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HAVLF | HAVN LIFE SCIENCES INC. | USD 0 | ▲ 0% |
| BETRF | BETTERLIFE PHARMA INC. | USD 0.15 | ▼ 13.45% |
| DHTI | Dalrada Technology Group Inc. | USD 0.01 | ▼ 42.11% |
| MYCOF | MYDECINE INNOVATIONS GROUP INC | USD 0.8 | ▲ 0% |
| TRUFF | Red Light Holland Corp. | USD 0.02 | ▼ 8.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:54 UTC. This page is informational and not investment advice.